These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8476993)

  • 1. Regulation by sulphonate groups of complement activation induced by hydroxymethyl groups on polystyrene surfaces.
    Montdargent B; Maillet F; Carreno MP; Jozefowicz M; Kazatchkine M; Labarre D
    Biomaterials; 1993 Feb; 14(3):203-8. PubMed ID: 8476993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific interactions of polystyrene biomaterials with factor D of human complement.
    Pascual M; Plastre O; Montdargent B; Labarre D; Schifferli JA
    Biomaterials; 1993 Jul; 14(9):665-70. PubMed ID: 8399963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of functionalized polystyrene derivatives with the complement system in human serum.
    Montdargent B; Labarre D; Jozefowicz M
    J Biomater Sci Polym Ed; 1991; 2(1):25-35. PubMed ID: 1863575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of C3 fragments on top of adsorbed plasma proteins during complement activation on a model biomaterial surface.
    Andersson J; Ekdahl KN; Lambris JD; Nilsson B
    Biomaterials; 2005 May; 26(13):1477-85. PubMed ID: 15522749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
    Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
    Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on protein adsorption and activation of complement on hydrated aluminium surfaces in vitro.
    Tengvall P; Askendal A; Lundström I
    Biomaterials; 1998 May; 19(10):935-40. PubMed ID: 9690835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3.
    Pangburn MK; Schreiber RD; Müller-Eberhard HJ
    J Exp Med; 1981 Sep; 154(3):856-67. PubMed ID: 6912277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the complement system by polysaccharidic surfaces bearing carboxymethyl, carboxymethylbenzylamide and carboxymethylbenzylamide sulphonate groups.
    Toufik J; Carreno MP; Jozefowicz M; Labarre D
    Biomaterials; 1995 Sep; 16(13):993-1002. PubMed ID: 8580263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody restores human alternative complement pathway activation by mouse erythrocytes rendered functionally deficient by pretreatment with pronase.
    Moore FD; Austen KF; Fearon DT
    J Immunol; 1982 Mar; 128(3):1302-6. PubMed ID: 6915957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
    Fearon DT
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5867-71. PubMed ID: 293688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of the complement binding properties of polystyrene: effects of end-point heparin attachment.
    Nilsson UR; Larm O; Nilsson B; Storm KE; Elwing H; Nilsson Ekdahl K
    Scand J Immunol; 1993 Mar; 37(3):349-54. PubMed ID: 8441922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme.
    Kinoshita T; Takata Y; Kozono H; Takeda J; Hong KS; Inoue K
    J Immunol; 1988 Dec; 141(11):3895-901. PubMed ID: 3183384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational epitopes of C3 reflecting its mode of binding to an artificial polymer surface.
    Nilsson UR; Storm KE; Elwing H; Nilsson B
    Mol Immunol; 1993 Feb; 30(3):211-9. PubMed ID: 7679465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of high-affinity C5 convertases of the alternative pathway of complement.
    Rawal N; Pangburn M
    J Immunol; 2001 Feb; 166(4):2635-42. PubMed ID: 11160326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase.
    Pangburn MK; Müller-Eberhard HJ
    Biochem J; 1986 May; 235(3):723-30. PubMed ID: 3638964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-like functionalized polymer surfaces: discrimination between catalytic and adsorption processes during the course of thrombin inhibition.
    Charef S; Tapon-Bretaudière J; Fischer AM; Pflüger F; Jozefowicz M; Labarre D
    Biomaterials; 1996 May; 17(9):903-12. PubMed ID: 8718936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Segment spanning residues 727-768 of the complement C3 sequence contains a neoantigenic site and accommodates the binding of CR1, factor H, and factor B.
    Becherer JD; Alsenz J; Esparza I; Hack CE; Lambris JD
    Biochemistry; 1992 Feb; 31(6):1787-94. PubMed ID: 1371073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophil granule major basic protein regulates generation of classical and alternative-amplification pathway C3 convertases in vitro.
    Weiler JM; Gleich GJ
    J Immunol; 1988 Mar; 140(5):1605-10. PubMed ID: 3346544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of complement by covalent attachment of rosmarinic acid to activated C3b.
    Sahu A; Rawal N; Pangburn MK
    Biochem Pharmacol; 1999 Jun; 57(12):1439-46. PubMed ID: 10353266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased enzymatic activity of the alternative pathway convertase when bound to the erythrocytes of paroxysmal nocturnal hemoglobinuria.
    Parker CJ; Baker PJ; Rosse WF
    J Clin Invest; 1982 Feb; 69(2):337-46. PubMed ID: 6915939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.